FDA Adverse Event Malfunction Summary report: N

BD NEOFLON¿ PRO IV CATHETER

MDR report key: 14048397 · Received April 7, 2022

Report

Report Number
8041187-2022-00180
Event Type
Malfunction
Date Received
April 7, 2022
Date of Event
March 17, 2022
Report Date
September 2, 2022
Manufacturer
BECTON DICKINSON MEDICAL (SINGAPORE)
Product Code
FOZ
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE CORRECTED: D9: DEVICE AVAILABLE FOR EVAL NO. D9: RETURNED TO MANUFACTURER ON: NA. H6: INVESTIGATION SUMMARY : FIVE PHOTOS WERE RECEIVED BY OUR QUALITY TEAM FOR EVALUATION. FROM THE FIRST TWO PHOTOS, A 26G NEOFLON PRO USED SAMPLE WAS OBSERVED WITH THE NEEDLE PIERCED THROUGH THE CATHETER. A BLUNT NEEDLE CANNOT BE SEEN CLEARLY FROM THE RETURNED PHOTOS. FROM PHOTOS THREE AND FOUR, A PATIENT¿S ARM WAS OBSERVED WITH REDNESS AROUND THE WRIST AREA. THE FIFTH PHOTO SHOWS A TOP WEB OF BATCH 9242213 OF CATALOG 391380 AND ONE TOP WEB OF BATCH 0081014 OF CATALOG 391379, WHICH DOES NOT BELONG TO THE REPORTED COMPLAINT. A REVIEW OF THE INTERNAL MANUFACTURING DEVICE RECORDS AND RAW MATERIAL HISTORY FILES FOR THE REPORTED LOT NUMBER WAS PERFORMED AND NO RECORDED QUALITY PROBLEMS OR REJECTIONS TO THIS INCIDENT WERE FOUND. FROM THE RETURNED PHOTOS, BLOOD WAS OBSERVED IN THE CATHETER. THIS INDICATES A SUCCESSFUL PENETRATION. IT WOULD NOT BE POSSIBLE TO PENETRATE THE VEIN IF THE PRODUCT HAS THE NEEDLE PIERCED THROUGH THE CATHETER. THEREFORE, THE PROBABLE ROOT CAUSE FOR THE REPORTED DEFECT COULD BE DUE TO THE USER PARTIALLY WITHDRAWING THE NEEDLE FROM THE CATHETER AND UPON REINSERTION, THE NEEDLE PIERCED THROUGH THE CATHETER. THE MANUFACTURING PROCESS WAS REVIEWED. THERE IS A 100% ONLINE AUTOMATED VISION INSPECTION SYSTEM THAT CAN DETECT AND REJECT PRODUCT NOT MEETING THE LIE DISTANCE REQUIREMENT. IF THE CANNULA PIERCED THROUGH THE CATHETER IN THE MANUFACTURING PROCESS, THE DEFECTIVE PART WOULD BE REJECTED BY THE AUTOMATED VISION INSPECTION SYSTEM AS THE PRODUCT WOULD NOT HAVE ANY LIE DISTANCE. THE ENDOTOXIN LEVEL FOR THE REPORTED BATCH 9242213 AND BATCH 0081014 ARE ACCEPTABLE. AN ALLERGIC REACTION (REDNESS / HEMATOMAS) AT THE SITE OF INSERTION MAY HAVE OCCURRED DUE TO AN INCORRECT ASEPTIC TECHNIQUE OR DAMAGED PRODUCT PACKAGE THAT LED TO A STERILITY BREACH. AS NO SAMPLE WAS RETURNED, FURTHER INVESTIGATION CANNOT BE PERFORMED, AND A ROOT CAUSE CANNOT BE DETERMINED. H3 OTHER TEXT : SEE H10.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVAL YES, D9: RETURNED TO MANUFACTURER ON: 21-JUL-2022. H6: INVESTIGATION SUMMARY: FIVE PHOTOS AND TWO REPRESENTATIVE SAMPLES WERE RECEIVED BY OUR QUALITY TEAM FOR EVALUATION. FROM THE FIRST TWO PHOTOS, ONE 26G NEOFLON PRO USED SAMPLE WAS OBSERVED WITH THE NEEDLE PIERCED THROUGH THE CATHETER. A BLUNT NEEDLE CANNOT BE SEEN CLEARLY FROM THE PHOTO. THE THIRD AND FOURTH PHOTOS, A PATIENT¿S ARM WAS OBSERVED WITH REDNESS AROUND THE WRIST AREA. THE FIFTH PHOTO SHOWS A TOP WEB OF BATCH 9242213 AND A TOP WEB OF BATCH 0081014. THE TOP WEB OF BATCH 0081014 DOES NOT BELONG TO THE REPORTED COMPLAINT. THE REPRESENTATIVE SAMPLES RETURNED ARE OF BATCH 9263838 AND 9353151. BOTH SAMPLES DO NOT BELONG TO THE REPORTED COMPLAINT. THE RETURNED SAMPLES WERE SUBJECTED TO VISUAL INSPECTION AND PENETRATION TESTING. THE SAMPLES PASSED THE ACCEPTANCE CRITERIA, AND NO ABNORMALITIES WERE OBSERVED. A REVIEW OF THE INTERNAL MANUFACTURING DEVICE RECORDS AND RAW MATERIAL HISTORY FILES FOR THE REPORTED AND UNREPORTED LOT NUMBERS WAS PERFORMED AND NO RECORDED QUALITY PROBLEMS OR REJECTIONS TO THIS INCIDENT WERE FOUND. FROM THE RETURNED PHOTOS, BLOOD WAS OBSERVED IN THE CATHETER. THIS INDICATES A SUCCESSFUL PENETRATION. IT WOULD NOT BE POSSIBLE TO PENETRATE THE VEIN IF THE PRODUCT HAS THE NEEDLE PIERCED THROUGH THE CATHETER. THEREFORE, THE PROBABLE ROOT CAUSE FOR THE REPORTED DEFECT COULD BE DUE TO THE USER HAVING PARTIALLY WITHDRAWING THE NEEDLE FROM THE CATHETER AND UPON REINSERTING THE NEEDLE INTO THE VEIN, THE NEEDLE PIERCED THROUGH THE CATHETER AND DAMAGED THE CATHETER. THE MANUFACTURING PROCESS WAS REVIEWED. THERE IS A 100% ONLINE AUTOMATED VISION INSPECTION SYSTEM THAT CAN DETECT AND REJECT PRODUCT NOT MEETING THE LIE DISTANCE REQUIREMENT. IF THE CANNULA PIERCED THROUGH THE CATHETER IN THE MANUFACTURING PROCESS, THE DEFECT PART WOULD BE REJECTED BY THE AUTOMATED VISION INSPECTION SYSTEM AS THE PRODUCT WILL NOT HAVE ANY LIE DISTANCE. THE STERILIZATION RECORDS WERE REVIEWED, AND NO ABNORMALITIES WERE OBSERVED. BASED ON THE QUALITY TEAM'S INVESTIGATION, THE ROOT CAUSE OF THIS INCIDENT CANNOT BE DETERMINED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD NEOFLON¿ PRO IV CATHETER THE NEEDLE HAS GONE THROUGH THE CATHETER. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: TIP OF THE NEEDLE IS BLUNT AND HARD TO INSERT, CANNULA IS TO SOFT AND TO FLEXIBLE.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD NEOFLON¿ PRO IV CATHETER THE NEEDLE HAS GONE THROUGH THE CATHETER. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: TIP OF THE NEEDLE IS BLUNT AND HARD TO INSERT, CANNULA IS TO SOFT AND TO FLEXIBLE.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD NEOFLON¿ PRO IV CATHETER THE NEEDLE HAS GONE THROUGH THE CATHETER. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: TIP OF THE NEEDLE IS BLUNT AND HARD TO INSERT, CANNULA IS TO SOFT AND TO FLEXIBLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1869159 BD NEOFLON¿ PRO IV CATHETER INTRAVASCULAR CATHETER FOZ BECTON DICKINSON MEDICAL (SINGAPORE) 9242213

Patients

Seq Age Sex Outcome Treatment
1 Unknown